{"name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"18F-metaFluorobenzylguanidine","genericName":"18F-metaFluorobenzylguanidine","slug":"18f-metafluorobenzylguanidine","indication":"Neuroblastoma","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Rubidium-82","genericName":"Rubidium-82","slug":"rubidium-82","indication":"Myocardial perfusion imaging for detection of coronary artery disease","status":"marketed"}]}],"pipeline":[{"name":"18F-metaFluorobenzylguanidine","genericName":"18F-metaFluorobenzylguanidine","slug":"18f-metafluorobenzylguanidine","phase":"phase_2","mechanism":"18F-metaFluorobenzylguanidine is a radiopharmaceutical that selectively accumulates in neuroendocrine tumors, allowing for targeted imaging and therapy.","indications":["Neuroblastoma","Pheochromocytoma","Paraganglioma"],"catalyst":""},{"name":"Rubidium-82","genericName":"Rubidium-82","slug":"rubidium-82","phase":"marketed","mechanism":"Rubidium-82 is a positron-emitting radioisotope that accumulates in myocardial tissue proportional to blood flow, allowing visualization of cardiac perfusion via PET imaging.","indications":["Myocardial perfusion imaging for detection of coronary artery disease","Assessment of myocardial viability in patients with coronary artery disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}